Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

NCT ID: NCT04828603

Last Updated: 2025-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-10-31

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any individual with possible allergy

Exclusion Criteria

* Patients with special risks attendant to venipuncture will be excluded
Minimum Eligible Age

1 Week

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Crown Fundation

UNKNOWN

Sponsor Role collaborator

Sunshine Foundation

UNKNOWN

Sponsor Role collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

National Human Genome Research Institute (NHGRI)

NIH

Sponsor Role collaborator

Harvard School of Public Health (HSPH)

OTHER

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

R. Sharon Chinthrajah

Associate Professor & Director, Clinical Translational Research Unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

R. Sharon Chinthrajah, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sean N. Parker Center for Allergy and Asthma Research, Stanford University

Palo Alto, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SNP Center Inquiry

Role: CONTACT

(650) 521-7237

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

SNP Center Inquiry

Role: primary

650-521-7237

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01AI165866-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

1DP2HG012480-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

8629

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Angioedema Biomarker Research Study
NCT06210698 NOT_YET_RECRUITING
Allergic Disease Onset Prevention Study
NCT05003804 COMPLETED PHASE1/PHASE2